Labshake search
Citations for R&D Systems :
601 - 650 of 1035 citations for 7 4 Aminobenzamido 4 hydroxynaphthalene 2 sulfonic acid since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2023Quote: ... Human IL-2 was from R&D Systems (Minneapolis, MN). Vero E6 cells were purchased from ATCC ...
-
bioRxiv - Bioengineering 2023Quote: ... 2 mg/mL Cultrex® Collagen (R&D Systems, 344702001) solution in neuron media ...
-
bioRxiv - Immunology 2023Quote: ... fibroblast growth factor-2 (FGF-2;20ng/mL;R&D systems) and Platelet-derived growth factor (PDGF-AA;20ng/mL;R&D systems ...
-
bioRxiv - Immunology 2023Quote: ... Then biotinylated Spike proteins (WA-2, 2P, R&D systems) were subsequently captured to a level of 3-500RU by the neutravidin ...
-
bioRxiv - Immunology 2024Quote: ... 30 IU/ml recombinant human IL-2 (R&D Systems) and 50 µM β-mercaptoethanol (Fisher) ...
-
bioRxiv - Cell Biology 2022Quote: ... The floating cells were collected by centrifugation and the cells were resuspended in microglia media (DMEM/F12 + 1X Glutamax + 1X Sodium pyruvate + 0.1% of fatty acid-free bovine serum albumin and 1X penicillin/streptomycin + 1X ITS supplement (R&D Systems AR013) + 25 ng/mL M-CSF (GoldBio 1320-09-10) ...
-
bioRxiv - Physiology 2020Quote: ... and probed with either an affinity-purified antibody fraction of mouse antiserum to a synthetic peptide of human cystatin-s corresponding to amino acid residues 21-141 (AF1296, R&D Systems) or an affinity-purified goat antibody raised against a peptide mapping at the C-terminus of human amylase (sc-12821 ...
-
bioRxiv - Cell Biology 2021Quote: The cell culture medium was pre-heated to 60°C for 5 mins prior to the addition of fatty acids (400μM oleic acid or 400μM palmitic acid or ethanol control), without (DMSO control) or with DGAT inhibitors as specified (A922500, PF04620110 or PF 06424439 (R&D system)) ...
-
bioRxiv - Immunology 2023Quote: ... Total TGF-β levels were determined by acid activation of the latent TGF-β1 in the sample using the sample activation kit 1 (DY010) (R&D Systems).
-
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccinebioRxiv - Immunology 2022Quote: ... plates were incubated for 2 h at RT with 500 ng/mL (25 ng/well) recombinant biotinylated human ACE-2 (R&D Systems, Cat# BT933-020) diluted in PBSTBA ...
-
bioRxiv - Immunology 2023Quote: ... and were cultured with 50U/ml hIL-2 (Th0) or 100U/ml hIL-2 and 5ng/ml murine TGFβ (R&D Systems, 7666-MB/CF) for 4-5 days.
-
bioRxiv - Neuroscience 2021Quote: ... Nrp1-Fc fusion protein containing the extracellular domain of rat Nrp1 (amino acid 22-854 minus 811-828; R&D Systems, 566-NNS) or the control human Fc dimer (R&D Systems ...
-
bioRxiv - Genomics 2024Quote: ... 5 mM beta-glycerophosphate and 1% insulin-transferrin-selenous acid (osteogenic media) and stimulated them the next day with recombinant human BMP2 (300 ng/ml) (R&D Systems, MN) in serum-free osteogenic media ...
-
bioRxiv - Developmental Biology 2021Quote: ... 2 ng/ml SCF (R&D Systems, cat. 455-MC-010), 500 ng/ml EGF (R&D Systems ...
-
bioRxiv - Neuroscience 2021Quote: ... and 2 ng/ml GDNF (R&D Systems 212-GD-050). Cells conditioned the media for 3 days at 5% CO2 in a 37°C incubator ...
-
bioRxiv - Immunology 2021Quote: ... 10 U/mL IL-2 from R&D Systems (1150-ML), 5 U/mL IL-12 p70 from PeproTech (210-12) ...
-
bioRxiv - Neuroscience 2019Quote: ... and glial derived neurotrophic factor (2 ng/ml; R&D Systems). One day after the initiation of differentiation ...
-
bioRxiv - Immunology 2019Quote: ... with addition of rhIL-2 (R&D Systems, 300 IU/ml). After 3 days ...
-
bioRxiv - Bioengineering 2021Quote: ... binding to basic fibroblast growth factor (FGF-2, R&D systems) and Vascular Endothelial Growth Factor 165 (VEGF165 ...
-
bioRxiv - Microbiology 2020Quote: ... and 2 ng/ml recombinant mouse TGF-β (R&D Systems). Cells were incubated with bacterial lysates at 37°C for 72 hours ...
-
bioRxiv - Neuroscience 2022Quote: ... goat anti-Lipocalin-2 (Lcn2) (1:200, R&D systems, AF1857), goat anti-Clusterin (Clu ...
-
bioRxiv - Immunology 2022Quote: ... and Human ULBP-2 DuoSet ELISA (R&D Systems, Cat. DY1298) kits according to the manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2022Quote: ... and recombinant human IFNγ (2 IU/mL, R&D Systems, 285IF) for 16-20 hours ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 2 ng/μL rhIFNγ (R&D Systems, 285-IF-100). Cell were incubated at 37 C 5% CO2 and 24 hours later ...
-
bioRxiv - Microbiology 2020Quote: ... supplemented with 2% fetal bovine serum (R&D systems, Cat# S11150) and 20U/mL Penicillin-Streptomycin (Gibco ...
-
bioRxiv - Neuroscience 2022Quote: ... Basic fibroblast growth factor (FGF-2, 20ng/ml, R&D systems) and epidermal growth factor EGF (10ng/ml ...
-
bioRxiv - Cancer Biology 2022Quote: ... the Human TGF-beta 2 Quantikine ELISA Kit (R&D Systems), and the Human TGF-beta 3 DuoSet ELISA Kit (R&D Systems).
-
bioRxiv - Cell Biology 2019Quote: ... and recombinant syndecan-2 (R&D Systems Cat#6585-SD-050), proteome profiler human phospho-kinase array kit (R&D Systems Cat#ARY003B) ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: IGF-2 (catalog #792-MG, R&D Systems, Inc., Minneapolis, MN) was dissolved in 0.1% bovine serum albumin (BSA ...
-
bioRxiv - Cancer Biology 2021Quote: Human Lipocalin-2/NGAL Quantikine ELISA Kits (#DLCN20, R&D Systems) were used to measure the levels of LCN2 in the cell lines according to the manufacturer’s instructions ...
-
bioRxiv - Immunology 2019Quote: 2 μg of CCL7 in 200 μl PBS (R&D Systems) was injected subcutaneously into mice at 6 weeks of age ...
-
bioRxiv - Cell Biology 2019Quote: ... VEGFR-2 and recombinant human Heparanase were from R&D Systems Inc ...
-
bioRxiv - Immunology 2020Quote: ... and recombinant human Ace-2 (R&D Systems #933-ZN-010) were diluted in OptiMEM to the desired concentrations ...
-
bioRxiv - Cell Biology 2021Quote: ... 2) TGFβ2 (2.5 ng/ml; R&D Systems, Minneapolis, MN, USA), 3 ...
-
bioRxiv - Cell Biology 2020Quote: ... and 2 μg/mL fibronectin (1918-FN, R&D System, USA) in PBS buffer was incubated on a glass-bottom petri dish (D35-14-1.5-N ...
-
bioRxiv - Immunology 2021Quote: ... goat angiotensin converting enzyme 2 (ACE2;R&D Systems; 1:500), rabbit transmembrane serine protease 2 (TMPRSS2 ...
-
bioRxiv - Immunology 2021Quote: ... and 30 IU/ml recombinant human IL-2 (R&D Systems). Prior to transduction with VSVGwt viruses ...
-
bioRxiv - Neuroscience 2021Quote: ... and 2 ng/ml GDNF (R&D Systems 212-GD-050) for a pre-differentiation phase of two days ...
-
bioRxiv - Bioengineering 2023Quote: ... and 0.2 ng mL−1 basic FGF-2 (R&D systems). Half of the medium was changed on day 3 ...
-
bioRxiv - Bioengineering 2023Quote: Recombinant SARS-CoV-2 proteins were purchased from R&D systems. For vaccination ...
-
bioRxiv - Immunology 2023Quote: ... Mouse Lipocalin-2/NGAL DuoSet ELISA kit by R&D Systems was used following the manufacturer’s protocol.
-
bioRxiv - Immunology 2023Quote: ... 10 U/mL human rIL-2 (202-IL, R&D Systems) was added to expand the T cells ...
-
bioRxiv - Bioengineering 2023Quote: ... BMP-2 Quantikine ELISA Kit (biotechne®, R&D systems, UK); alcian blue 8X ...
-
bioRxiv - Cell Biology 2023Quote: ... and 20 ng/ml FGF-2 (R&D Systems, Minneapolis, MN). Media were changed daily ...
-
bioRxiv - Cancer Biology 2023Quote: ... homogenized and digested in Cell Lysis Buffer #2 (R&D Systems) containing protease inhibitors on ice for 1 hour ...
-
bioRxiv - Developmental Biology 2023Quote: ... Goat anti-Runx 2 (1:100; R&D Systems AF2006-SP) and mouse anti-GM130 (1:100 ...
-
bioRxiv - Immunology 2024Quote: Recombinant human IL-2 (Proleukin) was purchased from R&D Systems or obtained from the National Cancer Institute’s Biological Research Branch ...
-
bioRxiv - Neuroscience 2023Quote: ... Ara-C and 2% low-hemoglobin FBS (R&D systems #S11510). iGLUT neurons were distributed among wells (500-750k cells per 24wp or 0.75-1.5E6 cell per 12wp ...
-
bioRxiv - Developmental Biology 2024Quote: For the goat anti-Brachyury antibody (R&D Systems, Table 2), the following protocol was employed ...
-
bioRxiv - Immunology 2024Quote: ... and 100 U/ml IL-2 (R&D Systems, Minneapolis, MN). NK-92 cells were passaged in 2–3 day interval to maintain the cell density at 2.5 × 105 – 1 × 106 cells/ml ...